North America Molecular Diagnostics Market To Gain Substantial Growth During The Forecast Period 2021-2024

North America Molecular Diagnostics Market To
Gain Substantial Growth During The Forecast
Period 2021-2024
“North America molecular diagnostics industry is estimated to grow at a significant CAGR in the upcoming
period as the scope and its applications are increasing enormously.”
North America Molecular Diagnostics Market is expected to reach USD 7.2 billion by 2024. Molecular diagnostics is
a branch of clinical pathology or laboratory medicine that uses techniques of molecular biology to diagnose disease,
monitor the effectiveness of therapies, predict diseases course, and select therapy. North America molecular
diagnostics industry is estimated to grow at a significant CAGR in the upcoming period as the scope and its
applications are increasing enormously.
The factors that are playing a major role in the growth of North American molecular diagnostics market area
technological enhancement in molecular diagnostic kits and rising R&D activities by manufacturers. North America
molecular diagnostics market is segmented based on product type, rest location, technology, application, and region.
Reagents, instruments, and the other product types could be explored in North American molecular diagnostics in
the forecast period. Reagents sector accounted for the significant market share of North America molecular
diagnostics and is estimated to continue with its dominance in the years to come. The reason could be increasing use
of these tests in a nonmedical sector like home and molecular diagnostic sector.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/north-america-molecular-diagnostics-market
Central laboratories, point-of-care, self-test, and others could be explored in North America molecular diagnostics in
the forecast period. Central laboratories sector accounted for the significant market share of North America
molecular diagnostics. The reason behind the overall market growth could be the presence of ancillary support. In
addition, the point-of-care sector is estimated to grow at the highest CAGR in the years to come.

Based on technology, transcription mediated amplification, polymerase chain reaction (PCR), sequencing, in situ
hybridization, mass spectrometry, isothermal nucleic acid amplification technology (INAAT), chips and microarrays,
and others could classify North America molecular diagnostics in the forecast period. The polymerase chain reaction
(PCR) sector accounted for the significant market share of North America molecular diagnostics and is estimated to
lead the overall market in the years to come. The reason could be high demand in molecular diagnostics.
The market could be categorized based on applications like microbiology, oncology, cardiovascular disease,
pharmacogenomics, neurological disease, infectious disease, genetic testing, and others could be explored in the
forecast period. Oncology sector accounted for the substantial market share of North America molecular diagnostics
and is estimated to continue its dominance in the years to come. The reason could be the rising occurrence of cancer
and increasing enhanced diagnostic tests. The sector is also estimated to grow at the highest CAGR in the years to
come.
The United States accounted for the substantial market share of North America molecular diagnostics and is
estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the
presence of key manufacturers in this region and raised awareness of personalized medicines. Canada is estimated
to follow the suit.
The key players of North America molecular diagnostics market are QIAGEN, Abbott Laboratories, Dako, Roche
Diagnostics, Danaher Corporation, Hologic, Inc., Dickinson and Company (BD), Novartis AG, BioMérieux SA, Bio-Rad
Laboratories, Inc., Siemens Healthineers GmbH, Alere, Sysmex Corporation, and Johnson & Johnson Services, Inc.
These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.
Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/north-america-molecular-diagnostics-market/request-sample
Market Segment:
North America Molecular Diagnostics Product Outlook (Market Revenue in USD Million, 2013 - 2024)
• Instruments
• Reagents
• Others
North America Molecular Diagnostics Test Location Outlook (Market Revenue in USD Million, 2013 - 2024)
• Point of care
• Self-testing or OTC
• Central laboratories

North America Molecular Diagnostics Technology Outlook (Market Revenue in USD Million, 2013 - 2024)
• PCR
• In-situ hybridization
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Chips and microarrays
• Mass spectrometry
• Sequencing
• Transcription-mediated amplification
• Others
North America Molecular Diagnostics PCR, by segments Outlook (Market Revenue in USD Million, 2013 - 2024)
• Multiplex PCR
• Others
North America Molecular Diagnostics Application Outlook (Market Revenue in USD Million, 2013 - 2024)
• Oncology
• Pharmacogenomics
• Infectious diseases
• Genetic testing
• Neurological diseases
• Cardiovascular diseases
• Microbiology
• Others
North America Molecular Diagnostics Oncology, by Application Outlook (Market Revenue in USD Million, 2013 -
2024)

• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Cervical Cancer
• Kidney Cancer
• Liver Cancer
• Blood Cancer
• Lung Cancer
• Others
North America Molecular Diagnostics Infectious Disease, by Application Outlook (Market Revenue in USD Million,
2013 - 2024)
• Methicillin-resistant Staphylococcus aureus (MRSA)
• Clostridium difficile
• Vancomycin-resistant enterococci
• Carbapenem-resistant bacteria testing
• Flu
• Respiratory syncytial virus (RSV)
• Candida
• Tuberculosis (TB) and drug-resistant TB
• Meningitis
• Gastrointestinal panel testing
• Chlamydia
• Gonorrhea

• HIV
• Hepatitis C
• Hepatitis B
• Others
North America Molecular Diagnostics Genetic Testing, by Application Outlook (Market Revenue in USD Million,
2013 - 2024)
• Newborn screening
• Predictive and presymptomatic testing
• Others
North America Molecular Diagnostics Country Outlook (Market Revenue in USD Million, 2013 - 2024)
• U.S.
• Canada
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/healthcare

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9
Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand
Galleria, Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com